Abstract The Alzheimer's Association International Conference held its sixth Satellite
Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian …

The Australian Imaging Biomarkers and Lifestyle (AIBL) study is a longitudinal study of 1112
volunteers from healthy, mild cognitive impairment, and Alzheimer's disease (AD) …

Worldwide there are over 46 million people living with dementia, and this number is
expected to double every 20 years reaching about 131 million by 2050. The cost to the …

Abstract The Australian Imaging Biomarkers and Lifestyle (AIBL) study is a longitudinal study
of 1,112 volunteers from healthy, mild cognitive impairment (MCI) and Alzheimer's disease …

Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study commenced in
2006 as a prospective study of 1,112 individuals (768 cognitively normal (CN), 133 with mild …

ABSTRACT Aotearoa New Zealand's population is ageing. Increasing life expectancy is
accompanied by increases in prevalence of Alzheimer's Disease (AD) and ageing-related …

The Canadian Institutes of Health Research (CIHR) is leading a new international effort to
further Alzheimer disease research, with a focus on early detection and prevention.“What we …

Alzheimer's disease neuropathology (amyloid, tauopathies) and brain atrophy are present
decades prior to manifestation of clinical symptoms. With the failure of treatment trials it is …

Background: The potential to optimize treatment and preventative strategies in the delay and
prevention of Alzheimer's disease (AD) relies in part on the capacity to make early …

Background: Quantifying the contribution of cerebrovascular disease to the clinical and
pathological profile of Alzheimer's disease is challenging. Objective: We aimed to determine …